{{Multiple issues|
{{Expand English|time=2021-12-8}}{{refimprove|time=2017-12-24T17:52:23+00:00}}}}{{Medical}}{{Drugbox
| verifiedrevid = 470620651
| IUPAC_name = 3α,7β-dihydroxy-5β-cholan-24-oic acid<br />OR<br />(''R'')-4-((3''R'',5''S'',7''S'',8''R'',9''S'',10''S'',13''R'',14''S'',17''R'')-3,7-dihydroxy-<br />10,13-dimethylhexadecahydro-<br />1''H''-cyclopenta[''a'']phenanthren-17-yl)pentanoic acid
| image = Ursodeoxycholic acid (UDCA) Structural Formula V1.svg
| width = 300
| image2 = Ursodeoxycholic acid ball-and-stick.png
| width2 = 300 
| drug_name = Ursodeoxycholic acid
<!--Clinical data-->
| tradename = Actigall
| Drugs.com = {{drugs.com|monograph|ursodiol}}
| licence_EU = <!-- EMEA requires brand name -->
| licence_US = Ursodiol
| pregnancy_AU = B3
| pregnancy_US = B
| pregnancy_category =  
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| legal_status =  
| dependency_liability =  
| routes_of_administration =  oral
| MedlinePlus = a699047
| DailyMedID = 19396
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =
<!--Identifiers-->
| IUPHAR_ligand = 7104
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 128-13-2
| ATC_prefix = A05
| ATC_suffix = AA02
| ATC_supplemental =  
| PubChem = 31401
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01586
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 29131
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 724L30Y2QR
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00734
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 9907
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1551
| PDB_ligand = IU5
<!--Chemical data-->
| C=24 | H=40 | O=4
| molecular_weight = 392.56 g/mol
| smiles = O=C(O)CC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]4[C@H]2[C@@H](O)C[C@@H]3C[C@H](O)CC[C@@]34C)C
| InChI = 1/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
| InChIKey = RUDATBOHQWOJDD-UZVSRGJWBC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RUDATBOHQWOJDD-UZVSRGJWSA-N
| synonyms = ursodeoxycholic acid, Actigall, Ursosan, Urso, Urso Forte
| density =  
| melting_point = 203
| boiling_point =  
| solubility =  
| specific_rotation =  
| sec_combustion =  
}}

'''熊去氧胆酸'''（{{lang-en|Ursodeoxycholic acid}}，也被称为'''3α,7β-二羟基-5β-胆烷-24-羧酸'''，3α,7β-dihydroxy-5β-cholan-24-oic acid，[[缩写|缩写]] '''UDCA'''），是一种来自[[熊膽|熊膽]]的[[胆汁酸|胆汁酸]]<ref>{{Cite web|title=放過熊吧！可治療膽結石的熊膽早就能用化學合成|url=http://www.foodnext.net/news/newssafe/paper/4593761379|access-date=2021-12-08|last=|first=|work=食力 foodNEXT|language=zh-TW|archive-date=2021-12-08|archive-url=https://web.archive.org/web/20211208083041/https://www.foodnext.net/news/newssafe/paper/4593761379|dead-url=no}}</ref>，为次级胆汁酸，由初级胆汁酸经由[[细菌|细菌]]代谢生成。

== 参考文献 ==
{{Reflist}}

==外部链接==
* [http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699047.html Ursodeoxycholic acid information] {{Wayback|url=http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a699047.html |date=20081001222558 }} at [[MedlinePlus|MedlinePlus]]

{{Bile and liver therapy}}

[[Category:胆汁酸|Category:胆汁酸]]
[[Category:作用于胃肠系统与代谢的药物|Category:作用于胃肠系统与代谢的药物]]